|
Real-time Estimate
Cboe BZX
07:01:30 09/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 144.48 USD | -1.61% |
|
-0.02% | +20.15% |
| 10:25pm | RBC Lifts Price Target on Gilead Sciences to $126 From $123, Keeps Sector Perform Rating | MT |
| 08/10 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| Market Cap | 182B 163B 152B 138B 259B 17,635B 262B 1,821B 712B 8,961B 684B 669B 28,820B | P/E 2026 * |
-44.4x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 201B 179B 167B 152B 286B 19,455B 289B 2,009B 786B 9,886B 754B 738B 31,794B | EV / Sales 2026 * |
6.54x | EV / Sales 2027 * | 5.9x |
| Free-Float |
99.89% | Yield 2026 * |
2.24% | Yield 2027 * | 2.28% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Tradegate
| GIS | Real-time | |
|
Deutsche Boerse AG
| GIS | Delayed | |
|
Xetra
| GIS | Delayed | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Boerse Muenchen
| GIS | Real-time | |
|
Wiener Boerse
| GILD | End-of-day quote | |
|
CBOE
| Real-time | ||
|
London S.E.
| 0QYQ | Delayed | |
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| 0QYQ | Real-time |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -1.61% | ||
| 1 week | -0.02% | ||
| Current month | -1.06% | ||
| 1 month | +0.57% | ||
| 3 months | +8.58% | ||
| 6 months | +4.19% | ||
| Current year | +20.15% |
| 1 week | 142.6 |  | 148.6 |
| 1 month | 142.6 | | 154.2 |
| Current year | 116.88 | | 157.29 |
| 1 year | 114.02 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 22/9/26 | Exercice | Controller/Auditor | 5,214 | 0.0004% | ||
| 15/9/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | -0.02% | +24.71% | +96.47% | 182B | |
| -1.75% | +1.28% | +37.70% | +103.68% | 1,060B | |
| -0.58% | -0.79% | +35.29% | +61.87% | 623B | |
| -0.76% | +4.57% | +17.54% | +82.28% | 480B | |
| -1.32% | -0.99% | +64.80% | +36.26% | 352B | |
| -2.03% | +1.06% | +21.08% | +40.60% | 345B | |
| -1.92% | -0.29% | +10.54% | +33.58% | 274B | |
| -2.36% | -1.16% | -7.14% | +9.54% | 249B | |
| -1.96% | -0.03% | +38.19% | +49.94% | 223B | |
| -1.58% | -0.04% | -34.99% | -60.95% | 168B | |
| Average | -1.58% | -0.41% | +20.77% | +45.33% | 395.61B | |
| Weighted average by Cap. | -1.47% | +0.05% | +27.47% | +61.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.72B 27.44B 25.6B 23.25B 43.75B 2,976B 44.18B 307B 120B 1,512B 115B 113B 4,863B | 32.76B 29.26B 27.29B 24.79B 46.65B 3,173B 47.11B 328B 128B 1,612B 123B 120B 5,185B |
| Net income | -4.27B -3.82B -3.56B -3.23B -6.09B -414B -6.15B -42.75B -16.72B -210B -16.05B -15.7B -677B | 10.28B 9.18B 8.56B 7.78B 14.63B 995B 14.77B 103B 40.2B 506B 38.58B 37.74B 1,626B |
| Net Debt | 18.79B 16.78B 15.65B 14.22B 26.76B 1,820B 27.02B 188B 73.51B 925B 70.55B 69.02B 2,974B | 11.14B 9.94B 9.28B 8.43B 15.86B 1,079B 16.01B 111B 43.56B 548B 41.81B 40.9B 1,763B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/10/26 | USD 147.38 | +0.36% | 2,710,911 |
| 07/10/26 | USD 146.85 | +1.82% | 5,097,193 |
| 06/10/26 | USD 144.23 | -0.28% | 3,723,588 |
| 05/10/26 | USD 144.63 | -0.08% | 6,138,328 |
| 02/10/26 | USD 144.74 | -1.87% | 5,044,221 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
